|
Market Closed -
Nasdaq Stockholm
11:30:00 30/10/26 pm AEDT
|
5-day change | 1st Jan Change | ||
| 5.500 SEK | +6.38% |
|
-1.79% | -1.79% |
| 05/10 | Mendus appoints board member chief operating officer | FW |
| 05/10 | Mendus AB Announces Management Changes, Effective October 05, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 35.89M | - | ||||
| 63.77B | |||||
| 56.37B | |||||
| 54.62B | |||||
| 44.06B | |||||
| 42.11B |
- Stock Market
- Stocks
- IMMU Stock
- Charts Mendus AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
